Most Recent

image: Phase 3 Win for Gene Therapy

Phase 3 Win for Gene Therapy

By Kerry Grens | October 6, 2015

The treatment restored sight among people with an inherited visual impairment.

0 Comments

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By Jef Akst | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: New Way to Edit Genes

New Way to Edit Genes

By Jef Akst | October 1, 2015

Researchers develop a more-efficient method for rewriting DNA that could hold therapeutic value for HIV and other diseases.

0 Comments

image: Decon Recon

Decon Recon

By Sarah C.P. Williams | October 1, 2015

Published genomes are chock-full of contamination. But as awareness of the problem grows, so do methods to help combat it.

1 Comment

image: Lefties, Language, and Lateralization

Lefties, Language, and Lateralization

By Bob Grant | October 1, 2015

The long-sought genetic link between handedness and language lateralization patterns in the brain is turning out to be illusory.

0 Comments

image: Seeing Things

Seeing Things

By The Scientist Staff | October 1, 2015

In Oliver Sacks's 2009 TED Talk, the famed physician and writer describes the neurological nature of hallucinations.

0 Comments

image: Riboswitch Flip Kills Bacteria

Riboswitch Flip Kills Bacteria

By Ruth Williams | September 30, 2015

Scientists discover a novel antibacterial molecule that targets a vital RNA regulatory element.

4 Comments

image: CRISPR 2.0?

CRISPR 2.0?

By Jef Akst | September 28, 2015

A pioneer of the gene-editing technique discovers a protein that could improve its accuracy.

0 Comments

image: Local Microbes Give Wine Character

Local Microbes Give Wine Character

By Ruth Williams | September 24, 2015

Yeast strains from different regions of New Zealand generate wines with varying chemistries.

0 Comments

image: Venter Enters the Consumer Genomics Biz

Venter Enters the Consumer Genomics Biz

By Bob Grant | September 22, 2015

The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. Dartmouth Professor Investigated for Sexual Misconduct Retires
  4. North American Universities Increasingly Cancel Publisher Packages